drugset
drugset / Trial / NCT01876017

Safety and Efficacy of BMMNC in Patients With Chronic Renal Failure

NCT01876017 ↗

Phase 1/2 Unknown 15 enrolled Chaitanya Hospital, Pune
NaSingle-groupOpen-labelTreatment

Summary

This Study is single arm, single center trial to check the safety and efficacy of Autologous Bone Marrow derived Mono Nuclear Stem Cell (BMMNCs)for the patient with CRF

Timeline

Start
2014-09
Primary completion
2016-11
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous bone marrow mononuclear cells Cell therapy — Intravenous

Indications

chronic renal failure syndrome